Study first to show that RNA interference can facilitate vaccine development

December 11, 2008

Athens, Ga. - Pharmaceutical companies and universities are racing to develop drugs that use the gene silencing mechanism known as RNA interference to treat a host of diseases. Now, a new study opens up an entirely new possibility for this powerful tool: Researchers at the University of Georgia have demonstrated for the first time that RNA interference can be used as a tool in the development of vaccines.

"Our data suggest that, at least in an animal model system, an RNAi prophylactic treatment can reduce infection and disease pathogenesis while also acting like a vaccine to engender immunity that protects against subsequent re-infection," said Ralph Tripp, Georgia Research Alliance Eminent Scholar in Vaccine Development at the UGA College of Veterinary Medicine.

Tripp, whose results appear in the December issue of the Journal of Virology, co-authored the study with doctoral student Wenliang Zhang. Previous studies by Tripp and other researchers have shown that treating mice with a small interfering RNA (siRNA) drug can reduce the replication of respiratory syncytial virus and reduce the duration of illness. RSV is a common virus that causes flu-like symptoms in otherwise healthy adults but can be fatal in infants, the elderly and people with compromised immune systems. Work from the Tripp lab has already contributed to the testing of an RNAi therapeutic for RSV infection known as ALN-RSV01, which is undergoing phase II clinical trials initiated by Cambridge, Mass.-based Alnylam Pharmaceuticals, Inc. In the latest study, Tripp explored how a related drug impacts the body's ability to respond to later infection.

The researchers treated mice with the siRNA drug, and, for control groups, treated mice with a non-specific siRNA or saline. In prophylactic treatments in which the mice were given the drug 12 hours before RSV infection, the siRNA drug reduced the viral load by up to 80 percent compared to both controls. The drug also prevented detectable disease in the mice.

Tripp pointed out that RSV replication was reduced in a dose-dependent manner, meaning that the viral load decreased in proportion to the amount of drug administered. He said it's possible to halt viral replication entirely with higher doses of the drug, but that his goal was to expose the immune system to enough of the virus so that it could mount a strong response upon future exposure.

In the next phase of the study, the researchers took mice that three weeks earlier were exposed to RSV after being prophylactically treated with either the drug or the controls and challenged them with the virus for a second time. The researchers found that levels of specific cells associated with the memory immune response were substantially increased in the experimental group versus the control groups, while the mice treated with the siRNA drug had virus concentrations that were more than 80 percent less than the control groups and recovered an average of two days faster.

"This is the first study of its kind to show the utility of using any siRNA to improve the immune system's memory response to an infectious agent," Tripp said. "We were able to reduce virus replication enough to prevent the development of disease but still induce immunity later on."

Between 75,000 to 125,000 children under age one are hospitalized with complications of RSV annually, according to the Centers for Disease Control and Prevention. Tripp notes that there is currently no effective vaccine for the virus. Unlike most viruses, the exact same strain of RSV can infect the same person repeatedly. Scientists are just now beginning to understand the many ways in which RSV evades the memory immune response, but Tripp's finding reveals that keeping RSV replication and protein expression at a low level prevents the virus from eluding the immune system.

Tripp said preliminary data also suggest siRNA drugs are likely to behave as effective vaccines for other common viral diseases, such as influenza and measles, and may help control outbreaks of emerging infectious diseases.

"Making siRNAs today is relatively simple because most disease-causing viruses have been sequenced or have closely-related cousins with conserved regions in their genes that can be targeted," Tripp said. "So you could prophylactically treat an animal, challenge it with the virus and see if you get reduced replication of the virus and whether that is sufficient to vaccinate against future challenge. Our data suggest that this is going to be a good strategy."

The research was supported by the Georgia Research Alliance.

University of Georgia

RNA Interference Technology: From Basic Science to Drug Development
by Krishnarao Appasani (Editor), Andrew Fire (Editor), Marshall Nirenberg (Editor)

RNA Interference (RNAi) technology has rapidly become one of the key methods used in functional genomics. RNAi is used to block the expression of genes and create phenotypes that can potentially yield clues about the function of these genes. In the postgenomic era, the elucidation of the physiological function of genes has become the rate-limiting step in the quest to develop 'gene-based drugs' and RNAi could potentially play a pivotal role in the validation of such novel drugs. In this 2005 overview, the basic concepts and applications of RNAi biology are discussed. Leading experts from both academia and industry have contributed to this invaluable reference. The volume is forwarded by Andrew Fire, one of the winners of the 2006 Nobel Prize for the discovery of RNA Interference.

RNA Interference (Principles and Protocols Series)
by T Doran (Author), C Helliwell (Author)

The Principles & Protocols Series is designed for upper level undergraduates, postgraduates and researchers, particularly those new to a field. Books in the series outline the theoretical background to experimental approaches, followed by bullet-point protocols, which are generic and can be adapted for particular systems. RNA interference (RNAi) has been one of the most exciting and significant new methodologies to appear in the past decade, and it now finds widespread application. This methods manual provides an introduction to the phenomenon to RNA Interference and specific protocols for RNAi, in organisms from plants and C.elegans to Drosophila and mammals. Also included are chapters covering small hairpin RNAs and viral-induced gene silencing.

RNA Interference: From Biology to Clinical Applications (Methods in Molecular Biology)
by Wei-Ping Min (Editor), Thomas Ichim (Editor)

From the early days when RNA interference was a strange artifact in worms to the 2006 Noble Prize received by Fire and Mello and the current clinical trials, the field of RNA interference has grown at a breakneck pace. In RNA Interference: From Biology to Clinical Applications, expert contributors provide an overview of the most current science and protocols that span the biological disciplines from detailed nucleic acid chemistry, to pharmacology, to the manipulation of signal transduction pathways. Divided into three distinct sections, this volume delves into the physiology of RNA interference, RNA interference in the laboratory and siRNA delivery, and preclinical and clinical issues associated with the use of RNAi-inducing agents as drugs in order to stimulate new questions and offer...

RNA Interference and Viruses: Current Innovations and Future Trends
by Miguel Angel MartÃnez (Editor)

Since its discovery in 1998, RNA interference (RNAi) has heralded the advent of novel tools for biological research and drug discovery. This exciting new technology is emerging as a powerful modality for battling some of the most notoriously challenging viral clinical targets, such as the hepatitis C virus (HCV) and the human immunodeficiency virus (HIV). However, several critical issues associated with this novel technology must be resolved before it can progress to testing in human clinical trials, and these have been the target of intensive research in recent years. In this book, expert RNAi specialists from around the world have teamed up to produce a timely and thought-provoking review of the area. The two central themes are: 1) the latest findings on RNAi-virus interactions and 2)...

RNA Interference, Editing, and Modification: Methods and Protocols (Methods in Molecular Biology)
by Jonatha M. Gott (Editor)

A comprehensive collection of cutting-edge methods for elucidating the function of new genes and altering gene expression. These readily reproducible techniques can be used either in transient and stable gene splicing applied to worms, flies, trypanosomes, mammals, and plants, or in studying RNA editing mechanisms in a wide range of organisms, including systems that involve the conversion of one base to another and insertion/deletion editing. Topics of interest include stable and transient RNA interference, gene silencing, RNA editing, bioinformatics, small noncoding RNAs, and RNomics. Special attention is given to methods for the identification and characterization of small RNAs involved in RNA interference or modification.

RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development
by Paul H. Johnson (Editor), John J. Rossi (Editor)

RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.

RNA Interference in Practice
by Ute Schepers (Author)

This hands-on guide to RNA interference brings the power of targeted gene silencing to any laboratory with the basic equipment for handling nucleic acids. In easy-to-follow, step-by-step protocols you will learn:How RNAi works in worms, flies and mammalsHow to design the most efficient RNAi constructsHow to achieve transient, stable and conditional RNAi in cell culturesHow to determine the efficiency of an RNAi experimentand how to use RNAi for gene therapyAll the protocols have been thoroughly tested in the author's own laboratory, and she provides examples of successful experiments and troubleshooting hints to help in establishing your own successful RNAi experiments. Also includes a list of suppliers for RNAi reagents and equipment as well as a glossary of...

Methods in Enzymology, Volyme 392: RNA Interference
by David R. Engelke (Author), John J. Rossi (Author)

The critically acclaimed laboratory standard, Methods in Enzymology, is one of the most highly respected publications in the field of biochemistry. Since 1955, each volume has been eagerly awaited, frequently consulted, and praised by researchers and reviewers alike. The series contains much material still relevant today - truly an essential publication for researchers in all fields of life sciences.

RNA Interference will cover RNAi in non-vertebrates (plants, C. elegans, drosophila, and S. pombe), and Mammalian systems (human and non-human cells). This volume discusses extensive methodology related to delivery methods high throughput strategies and prospects as a human therapy agent.

* One of the most highly respected publications in...

RNA Interference (Current Topics in Microbiology and Immunology)
by Patrick J. Paddison (Editor), Peter K. Vogt (Editor)

In the last few years the major effect that RNAi has had in invertebrate systems like C.elegans and drosophila is beginning to take hold in mammalian systems through both single gene knockdown experiments and genome-scale screens. In the next decade, there will no doubt be both notable successes and failures as we attempt to apply this genetic tool to various biological problems for the first time in academia and industry. Through the introduction of RNAi, mammalian systems have finally gained admittance to the pantheon of model genetic systems.